Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
Zk1rkaxm5M2mA8k6
